Cartridge Plungers
Product Description
Aptar Pharma
-
FR
-
2015On CPHI since
-
5000+Employees
Company types
Primary activities
Categories
Aptar Pharma
-
FR
-
2015On CPHI since
-
5000+Employees
Company types
Primary activities
More Products from Aptar Pharma (44)
-
Product Other Solutions
Aptar Pharma offers diverse delivery options and aims to accelerate your drug development process while minimizing risks. Their solutions encompass oral, ear and throat, buccal, vaginal, and anal treatments.
-
Product Pulmonary Solutions & Respiratory Solutions
Aptar Pharma is a global leader in pulmonary drug delivery devices for asthma and COPD. We offer a wide range of pMDI technology platforms, including metering valves, dose counters, BAIs, and DPIs, designed to optimize treatment and management for patients.
-
Product Services
Aptar Pharma's specialized analytical, development and regulatory services contribute value throughout the entire drug development process, expediting progress and mitigating risks along the journey.
-
Product Solutions Aptar CSP Technologies
Aptar CSP Technologies is a leading expert in active material science solutions, specializing in delivering cutting-edge active packaging solutions designed to safeguard delicate products.
-
Product Aptar Pharma's PremiumCoat® Platform of Products, Data and Services
Aptar Pharma’s PremiumCoat® platform comprises an end-to-end package of products, data and services for containing and protecting sensitive drug formulations in vials or pre-filled syringes (PFS). PremiumCoat® ETFE film-coated Bromobutyl closure solutions include stoppers for 13mm/20mm vials, plungers for ... -
Product Aptar Digital Health's device with Mobile App for Allergen Immunotherapy Treatment (AIT) Patients
Aptar Digital Health has developed a device and mobile app that enhances adherence for Allergen Immunotherapy (AIT) patients. The connected device attaches to the primary packaging and records self-administration events, providing feedback to patients. Data is transferred to the app via Bluetooth®, ena... -
Product DF30 Primeless Metering Valve
Aptar Pharma's Primeless DF30 valve, based on the DF30, boosts dose efficiency, patient compliance, and eco-friendliness by eliminating priming.
-
Product e-Lockout
Aptar Pharma's e-Lockout ensures safe and compliant nasal drug delivery with locking and child-resistant features. It monitors drug amount and timing, enhances patient compliance, and prevents overdosing of potent drugs. EMEA approval obtained.
-
Product HeroTracker® Sense
HeroTracker® Sense converts a metered dose inhaler (pMDI) into a connected healthcare device, providing feedback on device usage and administration technique via a mobile app. This promotes patient compliance and adherence. The smart sensors collect healthcare analytics, enabling doctors and healthcare... -
Product PremiumFill®
PremiumFill® from Aptar Pharma guarantees lower embedded particles, improved particulate integrity, and reduced defects. It offers high compatibility with sensitive drugs, safeguarding their quality during storage.
-
Product Proventu
Aptar Pharma's Proventu offers a patient-friendly, fully recyclable tube closure for applying dermatological and pain relief medications. It features an innovative valve system and precise and hygienic dispensing. -
Product SimpliSqueeze®
Aptar Pharma's SimpliSqueeze® is a leading packaging and dispensing solution for liquid pharmaceuticals. It improves patient compliance and is preferred over traditional packaging by consumers.
Aptar Pharma resources (3)
-
Video Innovations in Inhalation
Aptar Pharma's presentation entitled "Innovations in Inhalation" explores the current extensive portfolio of high-quality OINDP (Orally Inhaled and Nasal Drug Products) delivery devices. The presentation also highlights Aptar Pharma's comprehensive services which support respiratory drug development, including device selection, formulation development, analytical methods, and regulatory support. A key focus of the talk is the introduction of Orbital, an innovative high payload DPI system designed to enhance drug delivery efficiency and patient compliance. This discussion aims to showcase Aptar Pharma's latest advancements in inhalation technology, emphasizing their commitment to improving patient care through innovative drug delivery systems. -
Video The Pharma Challenge With Scope 3 Emissions – Collaborative Ways to Reduce Our CO2 Footprint
Big Pharma reports that up to over 90% of their CO2 emissions are scope 3. This is not only a huge burden but also the most difficult part to influence for pharmaceutical industry. However, there are ways to manage and collaborate in the industry. Christophe Marie from Aptar Group will highlight how Aptar implemented specific targets with partners and suppliers to tackle the scope 3 challenge, coming from a consumer market perspective, extrapolating into the pharmaceutical business. Also, when talking about products we are increasingly facing requests to minimize our CO2 footprint in Pharma. A great example for collaborative approaches helping to de-risk and accelerate our clients’ low GWP pressurized Metered Dose Inhaler (pMDI) programs will be illustrated by Chris Baron, based on the transition of the current pMDIs to alternative low GWP propellant technologies. Join Christophe Marie and Chris Baron at CPHI to learn how Aptar Pharma supports more sustainable product -
Brochure Aptar Pharma Brochure
Aptar Pharma Brochure
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance